Furukawa Of Japan Co-Develops System To Find Tiny Breast Cancer Cells
This article was originally published in PharmAsia News
Japan's Furukawa has joined with a local university to develop an early diagnosis of breast cancer capable of finding tiny cancer cells. Furukawa and Tohoku University came up with a smaller version of a PET system that detects cells as small as a millimeter in diameter. The team behind the device expects to begin clinical trials next year, with a possibility of getting market approval in 2012 and an expectation of more than $25 million in sales. (Click here for more - a subscription may be required)
You may also be interested in...
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.
Fresenius Kabi’s Idacio biosimilar adalimumab rival to Humira will from the start of June be marketed in Germany by Medac, following a deal between the two companies.
Coronavirus Update: Roche Launches Remdesivir Plus Actemra Trial, GSK Plans 1bn Vaccine Adjuvant Doses
Roche is teaming up with Gilead on the combination trial, aiming to improve on results of remdesivir alone, which has failed to show mortality benefits in COVID-19 patients.